MedTrace Logo

Validation of a CDSA Strategy to Reduce Antibiotic Prescription in Senegal

NCT05050825 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 470

Last updated 2021-10-27

No results posted yet for this study

Summary

This trial aims to validate a novel clinical care strategy based on a electronic clinical decision support algorithm (CDSA) combined with point of care rapid diagnostic tests by evaluating its impact on antibiotic prescription and clinical outcome of children and adolescent presenting at primary healthcare facilities with non-severe acute illness compared to routine practice. The trial also aims to assess the usability of the CDSA strategy. The study will be conducted in primary healthcare facilities across different epidemiological regions of Senegal.

Conditions

Interventions

OTHER

Patient clinical management based on the CDSA strategy

The CDSA strategy is a combination of point of care tests (rapid diagnostic tests targeting malaria, dengue fever and streptococcus group a sore through) and a mHealth tool that provides patient management recommendations, including treatment, based on an algorithm integrating patient clinical signs and symptoms, history and diagnostic test results.

Sponsors & Collaborators

  • Institut Pasteur de Dakar

    collaborator OTHER

  • Ministry of Health, Senegal

    collaborator OTHER_GOV

  • Foundation for Innovative New Diagnostics, Switzerland

    lead OTHER

Principal Investigators

  • Fabien Taieb, MD · Institut Pasteur de Dakar

  • Aliou Barry, MD · Institut Pasteur de Dakar

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-03
Primary Completion
2021-11-30
Completion
2021-12-15

Countries

  • Senegal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05050825 on ClinicalTrials.gov